Drug company AstraZeneca and researchers at Oxford University have hit pause on the trial of their coronavirus vaccine. Regulators say they’re reviewing safety data after adverse reactions in one participant in the vaccine’s phase three trial. Ian Jones is a professor of virology at the University of Reading in the UK, and explains what this means to host Marco Werman.